Separation agreement with Dr. Sandison upon his separation from the Company
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 25, 2025 · updated by the 8-K of Jan 7, 2026
| Director | Source |
|---|---|
|
Jon Filderman
Joined Jan 7, 2026
|
|
|
Melissa Leonard
Joined Jan 7, 2026
|
|
|
Dalton Smart
Joined Jan 7, 2026
|
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Separation agreement with Dr. Sandison upon his separation from the Company
Grants of stock options and RSUs to named executive officers and stock options to directors
Purchased 20,000 shares of Series A Preferred Stock in the April 2024 private placement
Purchased 389,716 shares of Common Stock and 1,286,786 pre-funded warrants in the November 2024 private placement
Purchased 389,731 shares of Common Stock and 280,869 pre-funded warrants in the November 2024 private placement
Separate indemnification agreements requiring the Company to indemnify directors and executive officers for certain expenses
Loading...